Fig. 4From: A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinomaSNORD15A, SNORD35B and SNORD60 as biomarkers for early diagnosis of RCC. (A): SNORD15A, SNORD35B and SNORD60 were up-regulated in US of early-stage RCC patients (n = 57) compared with healthy controls (n = 131); (B): ROC curve analysis of SNORD15A, SNORD35B and SNORD60 and their combination for early-stage RCC diagnosis; ****P < 0.0001Back to article page